
Biotech startup with WashU DNA raises $172M in Series B funding
The St. Louis-based company was founded on technology licensed through the Office of Technology Management at Washington University in St. Louis.
The St. Louis-based company was founded on technology licensed through the Office of Technology Management at Washington University in St. Louis.
The device leverages brain-computer interface (BCI) technology developed at WashU.
SentiAR’s first product, the CommandEP system, is an augmented reality software used in cardiac procedures.
have received Frontiers of Imaging grants from the Chan Zuckerberg Initiative to further their research on biomedical imaging.
A COVID-19 vaccine developed at Washington University in St. Louis School of Medicine has been licensed by St. Louis biotech startup Precision Virologics.
The new test is faster and simpler than nasal and oral swab tests and enables screening on a massive scale.
A recent article in the St. Louis Post-Dispatch examines research from WashU innovator Hong Chen.
The U.S. Department of Defense’s National Security Innovation Network (NSIN) appointed Jake Laktas university program director for Washington University in St. Louis. Laktas is housed on the Danforth Campus, within the Office of Research Development under the Vice Chancellor for Research. In…
Erica Barnell, an MD/PhD candidate at Washington University School of Medicine in St. Louis, has been named to Forbes 30 Under 30 in the Healthcare category.